Transgene

AGM Information • May 23, 2018

Combined General Meeting of May 23, 2018

Strasbourg, France, May 23, 2018, 6:00 p.m. CET – Transgene's shareholders held their Combined General Meeting (ordinary and extraordinary) today, chaired by Philippe Archinard, Chairman and CEO, to approve the company financial statements for the year ended December 31, 2017 and to vote on the other resolutions submitted to their approval.

At the Combined General Meeting, the shareholders have voted the resolutions submitted, in accordance with the recommendations of the Board of Directors.

Contacts

Transgene:

Lucie Larguier Director Corporate Communications & IR +33 (0)3 88 27 91 04 investorrelations@transgene.fr

Media contacts:

Citigate Dewe Rogerson David Dible / Marine Perrier + 44 (0)20 7638 9571 transgene@citigatedr.co.uk